查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1462651

全球減重和肥胖管理市場預測（截至 2030 年）：按產品類型、年齡層、設備、服務、分銷管道、最終用戶和地區進行分析

Weight Loss and Obesity Management Market Forecasts to 2030 - Global Analysis By Product Type, Age Group, Equipment, Service, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

2023年全球減重及肥胖管理市場規模為2,829億美元，預估至2030年將達5,549億美元，預測期內年複合成長率為10.1%。幫助肥胖和超重人群減重或維持體重的技術和藥物包含在減重和肥胖管理市場中。

基本上，肥胖是一種長期的健康狀況，其特徵是體內脂肪異常沉積和累積。 BMI（身體質量指數）用於計算肥胖程度。用於減重和對抗肥胖的方法包括藥物、運動、營養補充和減重手術。

健康政策組織美國健康信託基金2021年發布的報告發現，美國肥胖危機已波及19個州，肥胖率超過35%。

肥胖率增加

由於久坐的生活方式、不健康的飲食習慣以及促進體重增加的環境因素的蔓延，肥胖流行已達到驚人的水平。人們越來越認知到與肥胖相關的健康風險，例如心血管疾病、糖尿病和某些癌症，這增加了對有效體重管理解決方案的需求。這種需求正在推動各種干涉措施的開發和採用，從生活方式改變計劃到藥物和外科手術。

成本高

與減重計畫相關的費用，如藥物、手術、諮詢和特殊飲食，可能會成為個人尋求幫助的障礙，特別是那些低收入和沒有足夠健康保險的人。這些干涉措施的經濟負擔常常阻礙人們尋求專業協助或遵循規定的治療計劃。然而，缺乏全面的減重服務保險使問題變得更加複雜，使許多人無法負擔必要的治療。結果是，獲得治療的機會差距不斷擴大，肥胖相關健康結果的不平等現象長期存在。

技術進步

創新技術正在提供從穿戴式健身追蹤器和行動應用程式到先進手術技術和藥物干涉的解決方案。這些進步使得能夠滿足個人需求和偏好的有針對性的、個人化的減重和肥胖管理策略成為可能。數位健康平台提供即時監控、資料分析和行為追蹤，幫助個人就其健康和生活方式選擇做出明智的決定。

缺乏有效的長期解決方案

儘管有許多減重干涉措施，但隨著時間的推移持續減重對許多人來說仍然是一個挑戰。流行的飲食、補充品和臨時生活方式的改變通常會產生初步效果，但效果往往是短暫的。缺乏持續影響會削弱消費者信心並阻礙市場成長。此外，肥胖是一種複雜的疾病，其原因有很多，包括遺傳、環境和行為因素，因此很難發展出普遍有效的治療方法。

COVID-19 的影響：

封鎖、行動限制和社交距離措施擾亂了世界各地人們的日常生活，減少了體力活動，並增加了久坐行為。壓力、焦慮和不確定性進一步導致了許多人不健康的飲食習慣和體重增加。相反，有些人利用這次大流行作為優先考慮健康並專注於減重目標的機會。遠端醫療和虛擬就診越來越受歡迎，允許遠端存取醫療保健專業人員和體重管理計劃。

預計健身器材領域在預測期內將是最大的

預計健身器材領域在預測期內將佔據最大佔有率。人們對肥胖相關健康風險的認知不斷提高，對方便有效的體重管理方法的需求也隨之增加。跑步機、文具自行車、橢圓機和舉重機等健身設備為使用者提供了多種選擇，可根據他們的喜好和能力進行身體活動。健身器材的這種便利性和多功能性使人們能夠積極主動地實現個人減重目標，從而推動市場成長。

預計瘦身中心細分市場在預測期內年複合成長率最高

瘦身中心部門預計將在預測期內實現盈利成長，因為它提供針對個人需求的個人化和全面的計劃，包括飲食計劃、運動習慣和醫療監督。隨著健康和健身意識的增強以及肥胖盛行率的不斷增加，越來越多的人開始向瘦身中心尋求專業指導和支持，以實現減重目標。

比最大的地區

預計亞太地區將在整個預測期內佔據最大的市場佔有率。隨著人們對肥胖對健康的負面影響的認知不斷增強，人們正在尋求適合其特定需求和情況的客製化解決方案。個人化的醫療方法，例如基因檢測、客製化飲食計劃和有針對性的運動方案，正在取得進展，因為它們比一般治療方法更有效、更永續。此外，穿戴式健身設備和行動健康應用程式使個人能夠監控自己的進展並就其健康之旅做出明智的決定。

年複合成長率最高的地區：

預計歐洲在預測期內將保持良好的成長。隨著這些地區的人們達到更高的收入水平，他們傾向於優先考慮健康和保健，包括體重管理和肥胖預防。這種需求激增對歐洲減重和肥胖管理產品和服務市場產生了重大影響。該行業的歐洲公司正在充分利用這一機會，擴大其業務和分銷網路，以滿足開發中國家日益成長的需求。因此，這些因素正在推動該地區的成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球減重與肥胖管理市場：依產品類型

  • 藥品
    • 伴隨藥物
    • 血清素受體促效劑
    • 脂肪酶抑制劑
    • GLP-1受體促效劑
    • 中樞促效劑
    • 其他藥品
  • 裝置
    • 胃電刺激系統
    • 排放系統
    • 胃內球囊系統
    • 胃束帶
    • 減肥吻合器裝置
    • 其他設備
  • 其他產品類型

第6章 全球減重與肥胖管理市場：依年齡層

  • 18歲以下
  • 18至35歲
  • 35歲至50歲
  • 50歲以上

第7章全球減重和肥胖管理市場：依設備分類

  • 心血管訓練設備
  • 健身器材
  • 肌力訓練器材
  • 手術器械
  • 其他設備

第8章全球減重和肥胖管理市場：依服務分類

  • 諮詢服務
  • 瘦身中心
  • 健身中心
  • 網路減重計畫
  • 其他服務

第9章全球減重和肥胖管理市場：按分銷管道

  • 零售
  • 醫藥店
  • 大賣場/超級市場
  • 其他分銷管道

第10章全球減重與肥胖管理市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 減重診所
  • 其他最終用戶

第11章全球減重和肥胖管理市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Allergan Plc
  • Allurion Technologies Inc
  • Amgen Inc
  • Apollo Endosurgery, Inc
  • Aspire Bariatrics
  • Eisai Co., Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Herbalife International of America, Inc
  • Medtronic
  • Novo Nordisk A/S
  • ReShape Lifesciences, Inc
  • Rhythm Pharmaceuticals, Inc
  • Takeda Pharmaceutical Company Limited
Product Code: SMRC25702

According to Stratistics MRC, the Global Weight Loss and Obesity Management Market is accounted for $282.9 billion in 2023 and is expected to reach $554.9 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Technologies and drugs that assist obese or overweight people in losing weight or maintaining their weight are included in the weight loss and obesity management market. Fundamentally, obesity is a long-term medical condition characterized by abnormal fat deposition and accumulation in the body. The Body Mass Index, or BMI, is used to compute it. Some of the methods used to address weight loss and obesity include medications, exercise, nutritional supplements, and weight reduction surgery.

According to a report published by Trust for America's Health, a health policy organization, in 2021, the nation's obesity crisis found that 19 states have obesity rates over 35 percent in U.S.

Market Dynamics:

Driver:

Increasing obesity rates

With a surge in sedentary lifestyles, unhealthy dietary habits, and environmental factors conducive to weight gain, the prevalence of obesity has reached alarming levels. As individuals become increasingly aware of the health risks associated with obesity, including cardiovascular diseases, diabetes, and certain types of cancer, there is a growing demand for effective weight management solutions. This demand fuels the development and adoption of various interventions, ranging from lifestyle modification programs to pharmaceuticals and surgical procedures.

Restraint:

High costs

The expenses associated with weight loss programs, including medications, surgery, counseling, and specialized diets, can pose a barrier to individuals seeking help, particularly those with lower incomes or inadequate health insurance coverage. The financial burden of these interventions often deters individuals from pursuing professional assistance or adhering to prescribed treatment plans. However, the lack of comprehensive insurance coverage for weight loss services further exacerbates the issue, leaving many individuals unable to afford essential treatments. As a result, disparities in access to care widen, perpetuating inequalities in health outcomes related to obesity.

Opportunity:

Technological advancements

Innovative technologies offer diverse solutions, ranging from wearable fitness trackers and mobile applications to advanced surgical techniques and pharmaceutical interventions. These advancements enable personalized and precise strategies for weight loss and obesity management, catering to individual needs and preferences. Digital health platforms provide real-time monitoring, data analysis, and behavior tracking, empowering individuals to make informed decisions about their health and lifestyle choices.

Threat:

Lack of effective long-term solutions

While numerous weight loss interventions exist, sustaining weight loss over the long term remains a significant challenge for many individuals. Fad diets, supplements and temporary lifestyle changes often yield initial results, but they frequently fail to provide lasting benefits. This lack of sustained efficacy undermines consumer confidence and hinders the growth of the market. Moreover, obesity is a complex condition with multifactorial causes, including genetic, environmental, and behavioral factors, making it difficult to develop universally effective treatments.

Covid-19 Impact:

Lockdowns, restrictions on movement, and social distancing measures led to disrupted routines, reduced physical activity, and increased sedentary behavior among populations worldwide. Stress, anxiety, and uncertainty further contributed to unhealthy eating habits and weight gain for many individuals. Conversely, some individuals used the pandemic as an opportunity to prioritize their health and focus on weight loss goals. Telehealth and virtual consultations surged in popularity, enabling remote access to healthcare professionals and weight management programs.

The fitness equipment segment is expected to be the largest during the forecast period

Fitness Equipment segment is expected to hold the largest share during the forecast period. With the rising awareness of the health risks associated with obesity, there's an increasing demand for convenient and effective ways to manage weight. Fitness equipment such as treadmills, stationary bikes, elliptical trainers, and weight lifting machines provide users with versatile options for engaging in physical activity tailored to their preferences and abilities. This accessibility and versatility of fitness equipment empower individuals to take proactive steps towards achieving their weight loss goals, thereby driving growth within the market.

The slimming centers segment is expected to have the highest CAGR during the forecast period

Slimming Centers segment is positioned to witness the profitable growth throughout the overcast period as it offers personalized, comprehensive programs tailored to individual needs, including diet plans, exercise routines, and often, medical supervision. With rising awareness about health and fitness, coupled with the increasing prevalence of obesity, more people are turning to slimming centers for professional guidance and support in achieving their weight loss goals.

Region with largest share:

Asia Pacific region dominated the largest share of the market throughout the estimated period. As awareness grows regarding the adverse effects of obesity on health, individuals are seeking tailored solutions that cater to their specific needs and circumstances. Personalized healthcare approaches, such as genetic testing, customized diet plans, and targeted exercise regimens, are gaining traction as they offer more effective and sustainable results compared to generic treatments. Moreover, wearable fitness devices and mobile health apps, empower individuals to monitor their progress and make informed decisions about their health journey.

Region with highest CAGR:

Europe region is poised to hold lucrative growth over the projection period. As individuals in these regions attain higher levels of income, they tend to prioritize health and wellness, including efforts to manage weight and combat obesity. This burgeoning demand has had a notable impact on the European market for weight loss and obesity management products and services. European companies in this sector are capitalizing on the opportunity by expanding their operations and distribution networks to cater to the growing demand from developing countries. As a result, these elements are boosting the regional growth.

Key players in the market

Some of the key players in Weight Loss and Obesity Management market include Allergan Plc, Allurion Technologies Inc, Amgen Inc, Apollo Endosurgery, Inc, Aspire Bariatrics, Eisai Co., Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Herbalife International of America, Inc, Medtronic, Novo Nordisk A/S, ReShape Lifesciences, Inc, Rhythm Pharmaceuticals, Inc and Takeda Pharmaceutical Company Limited.

Key Developments:

In March 2023, PRISTYN CARE, a healthcare service provider, announced that it has entered into a strategic partnership with Allurion, a company developing a medical device for weight loss, in order to offer a weight-loss and obesity care platform.

In December 2022, Amgen Inc., announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule. This first-in-human study was designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of AMG 133 in people with obesity and without diabetes.

Product Types Covered:

  • Drugs
  • Devices
  • Other Product Types

Age Groups Covered:

  • Under 18 Years
  • 18 To 35 Years
  • 35 To 50 Years
  • Above 50 Years

Equipments Covered:

  • Cardiovascular Training Equipment
  • Fitness Equipment
  • Strength Training Equipment
  • Surgical Equipment
  • Other Equipments

Services Covered:

  • Consulting Services
  • Slimming Centers
  • Fitness Centers
  • Online Weight Loss Programs
  • Other Services

Distribution Channels Covered:

  • Retail Sales
  • Pharmaceutical Stores
  • Hypermarket/ Supermarket
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centres
  • Weight Loss Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Weight Loss and Obesity Management Market, By Product Type

  • 5.1 Introduction
  • 5.2 Drugs
    • 5.2.1 Combination Drugs
    • 5.2.2 Serotonin Receptor Agonists
    • 5.2.3 Lipase Inhibitors
    • 5.2.4 GLP-1 Receptor Agonists
    • 5.2.5 Centrally Acting Drugs
    • 5.2.6 Other Drugs
  • 5.3 Devices
    • 5.3.1 Gastric Electrical Stimulation Systems
    • 5.3.2 Gastric Emptying Systems
    • 5.3.3 Gastric Balloon Systems
    • 5.3.4 Gastric Bands
    • 5.3.5 Bariatric Stapling Devices
    • 5.3.6 Other Devices
  • 5.4 Other Product Types

6 Global Weight Loss and Obesity Management Market, By Age Group

  • 6.1 Introduction
  • 6.2 Under 18 Years
  • 6.3 18 To 35 Years
  • 6.4 35 To 50 Years
  • 6.5 Above 50 Years

7 Global Weight Loss and Obesity Management Market, By Equipment

  • 7.1 Introduction
  • 7.2 Cardiovascular Training Equipment
  • 7.3 Fitness Equipment
  • 7.4 Strength Training Equipment
  • 7.5 Surgical Equipment
  • 7.6 Other Equipments

8 Global Weight Loss and Obesity Management Market, By Service

  • 8.1 Introduction
  • 8.2 Consulting Services
  • 8.3 Slimming Centers
  • 8.4 Fitness Centers
  • 8.5 Online Weight Loss Programs
  • 8.6 Other Services

9 Global Weight Loss and Obesity Management Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Retail Sales
  • 9.3 Pharmaceutical Stores
  • 9.4 Hypermarket/ Supermarket
  • 9.5 Other Distribution Channels

10 Global Weight Loss and Obesity Management Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgery Centres
  • 10.4 Weight Loss Clinics
  • 10.5 Other End Users

11 Global Weight Loss and Obesity Management Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Allergan Plc
  • 13.2 Allurion Technologies Inc
  • 13.3 Amgen Inc
  • 13.4 Apollo Endosurgery, Inc
  • 13.5 Aspire Bariatrics
  • 13.6 Eisai Co., Ltd
  • 13.7 F. Hoffmann-La Roche Ltd
  • 13.8 GlaxoSmithKline plc
  • 13.9 Herbalife International of America, Inc
  • 13.10 Medtronic
  • 13.11 Novo Nordisk A/S
  • 13.12 ReShape Lifesciences, Inc
  • 13.13 Rhythm Pharmaceuticals, Inc
  • 13.14 Takeda Pharmaceutical Company Limited

List of Tables

  • Table 1 Global Weight Loss and Obesity Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Weight Loss and Obesity Management Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Weight Loss and Obesity Management Market Outlook, By Drugs (2021-2030) ($MN)
  • Table 4 Global Weight Loss and Obesity Management Market Outlook, By Combination Drugs (2021-2030) ($MN)
  • Table 5 Global Weight Loss and Obesity Management Market Outlook, By Serotonin Receptor Agonists (2021-2030) ($MN)
  • Table 6 Global Weight Loss and Obesity Management Market Outlook, By Lipase Inhibitors (2021-2030) ($MN)
  • Table 7 Global Weight Loss and Obesity Management Market Outlook, By GLP-1 Receptor Agonists (2021-2030) ($MN)
  • Table 8 Global Weight Loss and Obesity Management Market Outlook, By Centrally Acting Drugs (2021-2030) ($MN)
  • Table 9 Global Weight Loss and Obesity Management Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 10 Global Weight Loss and Obesity Management Market Outlook, By Devices (2021-2030) ($MN)
  • Table 11 Global Weight Loss and Obesity Management Market Outlook, By Gastric Electrical Stimulation Systems (2021-2030) ($MN)
  • Table 12 Global Weight Loss and Obesity Management Market Outlook, By Gastric Emptying Systems (2021-2030) ($MN)
  • Table 13 Global Weight Loss and Obesity Management Market Outlook, By Gastric Balloon Systems (2021-2030) ($MN)
  • Table 14 Global Weight Loss and Obesity Management Market Outlook, By Gastric Bands (2021-2030) ($MN)
  • Table 15 Global Weight Loss and Obesity Management Market Outlook, By Bariatric Stapling Devices (2021-2030) ($MN)
  • Table 16 Global Weight Loss and Obesity Management Market Outlook, By Other Devices (2021-2030) ($MN)
  • Table 17 Global Weight Loss and Obesity Management Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 18 Global Weight Loss and Obesity Management Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 19 Global Weight Loss and Obesity Management Market Outlook, By Under 18 Years (2021-2030) ($MN)
  • Table 20 Global Weight Loss and Obesity Management Market Outlook, By 18 To 35 Years (2021-2030) ($MN)
  • Table 21 Global Weight Loss and Obesity Management Market Outlook, By 35 To 50 Years (2021-2030) ($MN)
  • Table 22 Global Weight Loss and Obesity Management Market Outlook, By Above 50 Years (2021-2030) ($MN)
  • Table 23 Global Weight Loss and Obesity Management Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 24 Global Weight Loss and Obesity Management Market Outlook, By Cardiovascular Training Equipment (2021-2030) ($MN)
  • Table 25 Global Weight Loss and Obesity Management Market Outlook, By Fitness Equipment (2021-2030) ($MN)
  • Table 26 Global Weight Loss and Obesity Management Market Outlook, By Strength Training Equipment (2021-2030) ($MN)
  • Table 27 Global Weight Loss and Obesity Management Market Outlook, By Surgical Equipment (2021-2030) ($MN)
  • Table 28 Global Weight Loss and Obesity Management Market Outlook, By Other Equipments (2021-2030) ($MN)
  • Table 29 Global Weight Loss and Obesity Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 30 Global Weight Loss and Obesity Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 31 Global Weight Loss and Obesity Management Market Outlook, By Slimming Centers (2021-2030) ($MN)
  • Table 32 Global Weight Loss and Obesity Management Market Outlook, By Fitness Centers (2021-2030) ($MN)
  • Table 33 Global Weight Loss and Obesity Management Market Outlook, By Online Weight Loss Programs (2021-2030) ($MN)
  • Table 34 Global Weight Loss and Obesity Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 35 Global Weight Loss and Obesity Management Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 36 Global Weight Loss and Obesity Management Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 37 Global Weight Loss and Obesity Management Market Outlook, By Pharmaceutical Stores (2021-2030) ($MN)
  • Table 38 Global Weight Loss and Obesity Management Market Outlook, By Hypermarket/ Supermarket (2021-2030) ($MN)
  • Table 39 Global Weight Loss and Obesity Management Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 40 Global Weight Loss and Obesity Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 Global Weight Loss and Obesity Management Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 42 Global Weight Loss and Obesity Management Market Outlook, By Ambulatory Surgery Centres (2021-2030) ($MN)
  • Table 43 Global Weight Loss and Obesity Management Market Outlook, By Weight Loss Clinics (2021-2030) ($MN)
  • Table 44 Global Weight Loss and Obesity Management Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.